Sanjay S. Reddy, MD, FACS
- Request Appointment
- Clinical Locations
- About
- Education and Training
- Patient Stories
- Research Profile
- Publications
- Ratings
Clinical Locations
Primary Location
Fox Chase Cancer Center
333 Cottman Avenue
Philadelphia, PA 19111
About
Associate Professor, Department of Surgical Oncology
Attending Surgeon
Associate Program Director, Complex General Surgical Oncology Fellowship
Co-Director, Marvin & Concetta Greenberg Pancreatic Cancer Institute
Collaborating Member, Molecular Therapeutics
NCCN, Hepatobiliary Cancers Panel Member
Specialties
Treatment Focus
Hyperthermic intraperitoneal chemotherapy (HIPEC), gastric cancer, hepatobiliary cancer, general and minimally invasive surgery
Research Program
Treatment Philosophy
I decided to join the Fox Chase Cancer Center team in conquering cancer because I saw first-hand the dramatic difference we can make here. I decided to continue my training in Philadelphia after completing my general surgery residency in New York City, under the tutelage of my father, also a surgeon who spent many years treating cancer. I completed a two-year fellowship in complex surgical oncology at Fox Chase, working closely with various multidisciplinary teams in caring for patients with colorectal, liver, pancreatic and stomach cancers, in addition to melanoma and sarcomas. Being trained by leaders in the field, I had the unique opportunity to hone my skills and expertise, and apply them to my own clinical practice.
I have extensive training in traditional open surgery, as well as laparoscopic and robotic techniques, allowing me to offer individualized care to patients. I have particular interests in the management of sarcomas and colorectal, melanoma and pancreatic cancers. The implementation of minimally-invasive surgical techniques to the management of colorectal cancer is routinely offered at Fox Chase, and similar techniques are used to address pancreatic diseases. I also have a keen interest in the use of hyperthermic intraperitoneal chemotherapy (HIPEC), following cytoreductive surgery for cancer of the peritoneum, including appendix cancer, peritoneal mesothelioma and pseudomyxoma peritonei. In addition to this, there is a necessity to understand the benefit of, and perform further research, incorporating HIPEC in patients with colorectal and gastric cancers, which our team will explore further.
The benefit of an NCI-designated cancer center is that we are able to offer many innovative strategies in treating all types of cancers. Whether through a national clinical trial or particular surgical technique, we optimize patient care to the individual. I believe the physician-patient relationship is one of the foundations to building a plan to treat cancer, and I offer guidance through each stage of treatment. Medicine has always been a family-oriented field for me; with my father being a surgeon, and mother an anesthesiologist, I take great pride in offering compassion and honesty in formulating individualized treatment plans for every patient and his or her family.
Follow on Twitter: @FCCCSurgOnc
Education and Training
Educational Background
- Fellowship, Surgical Oncology Fellow, Fox Chase Cancer Center, Temple University Hospital, Philadelphia, PA
- Residency, General Surgery, Beth Israel Medical Center, New York, NY
Certifications
- Complex Surgical Oncology, 2014
- American Board of Surgery, 2012
- Board Certified in Complex Surgical Oncology
Memberships
- American College of Surgeons
- Clinical Robotics Surgical Association
- Association for Academic Surgery
- American Society of Clinical Oncology
- Society of Surgical Oncology
- Society for Surgery of the Alimentary Tract
- Pancreas Club
- American Cancer Society- Metropolitan Philadelphia Chapter
Honors & Awards
- Top Physicians Under 40 2020, Pennsylvania Medical Society
- The John (Drew) Ridge Fellowship Award in Surgical Oncology, 2014
- Resident Teaching Award, Beth Israel Medical Center, Albert Einstein College of Medicine,2011
- Resident Teaching Award, St. Vincent's Medical Center, New York Medical College, 2010
- Harriet Gold Foundation, Scholar in Humanism Award, New York Medical College, 2010
- Academic Achievement in Molecular Cell Biology, St. Vincent's Medical Center, New York, NY, 2009
- Pi Kappa Alpha, Honors Society, 2002-2003
- University of Connecticut Dean's List, 2002-2003
Patient Stories
Amy Wolf
Breast Cancer
Amy Wolf
Breast Cancer
My name is Amy Wolf and I am a breast cancer survivor who was treated at Fox Chase Cancer Center.
Before my diagnosis, I worked with preschoolers, acting as an aid for children with autism. After going in for an annual physical, my doctor felt a lump in my left breast, but when she placed my hand on it, I couldn’t feel it.
Alisa Monteiro
Neuroendocrine Tumors
Alisa Monteiro
Neuroendocrine Tumors
As someone who works in oncology clinical trials, I’m pretty familiar with hospitals and medical centers in the Philadelphia area and what their specialties are when it comes to cancer. Still, at the age of 52, I did not expect to be diagnosed with a neuroendocrine tumor, also known as NET, and be faced with the decision of where to go to receive the best treatment.
William Bojanowski
Neuroendocrine Tumors
William Bojanowski
Neuroendocrine Tumors
In October of 2020, at 59 years old, I started having some back pain. I worked in construction, so lower back pain was normal, but this time the pain was in my upper back. I went to my primary doctor and she noticed that my kidney was not functioning fully. She thought it might be due to my diabetes medication.
After two months of a lowered dosage of medication, my pain only got worse. I was sent to the local urologist, and when he saw something on my X-rays he immediately referred me to Fox Chase Cancer Center.
Monsignor Joseph A. Tracy
Pancreatic Cancer
Monsignor Joseph A. Tracy
Pancreatic Cancer
When I was diagnosed with pancreatic cancer at 46 years old, my goal was just to make it to 50. Even with that short-term goal, I knew the odds were not in my favor.
That was 15 years ago. I’ve made it well past my original goal, and my Fox Chase care team played a huge role in making that possible.
Diagnosing the Problem
Rodney Malarchik
Pancreatic Cancer
Rodney Malarchik
Pancreatic Cancer
[Treatment] is worthwhile because once you are on the other side, you have a promise of a future. That is impactful. You need to find a path through it if you can.
Pages
Research Profile
Research Program
Research Interests
My research interest for colorectal malignancies focuses on the use of national cancer databases to assess the accuracy of clinical staging, to see if this has improved over time, and to observe reporting standards between academic institutions versus other centers. As treatment of colorectal cancers involve multimodality planning, accurate clinical staging proves to be the foundation on how best to deliver care.
I also have a strong research interest in the vascular resectability staging of pancreatic cancer. Currently under review is our preoperative venous and arterial staging for borderline resectable pancreatic cancers and whether we are able to predict from preoperative imaging the likelihood of clear margin achievement and prognosis. As treatment of borderline resectable pancreatic cancer continues to evolve, accurate preoperative vascular resectability staging is imperative to assess and guide multimodality therapy.
Publications
Selected Publications
Tharmalingam S, Reddy S, Sharda P, Koch CA. Severe Hypocalcemia and transient hypoparathyroidism after hyperthermic intraperitoneal chemotherapy. Thieme Connect 2020;Aug 7
Moten AS, Movva S, von Mehren M, Wu H, Esnaola NF, Reddy SS, Farma JM. Granular cell tumor experience at a comprehensive cancer center. J Surg Res, 226:1-7, 2018. PubMed
Barnica VH, Reddy SS, Wu H, Fang Z, Olszanski A, Farma JM. High Mitotic Rates in Patients with Cutaneous Melanoma. (Manuscript pending publication).
Reddy SS, Cooper HS, Ruth K, Chun YS, Watson JC, Hoffman JP. The Role of Adjuvant Chemoradiotherapy in Pancreatobiliary versus Intestinal Subtypes of Ampullary Cancers. Gastroenterology. Volume 144(5). 1107-1108. (Manuscript pending publication).
Reddy SS, Boukovalas S, Barnica V, Fang Z, Wu H, Farma JM. The Presence of Tumor Infiltrating Lymphocytes and their Role as a Prognostic Indicator for Melanoma. (Manuscript pending publication).
Reddy SS, Hoffman JP. Letter to the Editor Referencing, Kelly et al, Vein Involvement during Pancreaticoduodenectomy: is there a need for Redefinition of “Borderline Resectable Disease?” Journal of Gastrointestinal Surgery. February 2014.
Reddy SS, Leitman IM. Blood Transfusions in the Surgical Patient: A Gift of Life, but at What Cost? J Surg Res. Volume 181 (2): 216-218. May 2013.
Reddy SS, Leitman IM. Pharmacotherapy for Traumatic Spinal Cord Injury: The Science Behind the Promise. J Surg Res. Volume 181(2): 222-224. May 2013.
Reddy SS, Bloom ND. En Bloc Resection of Extra-Peritoneal Soft Tissue Neoplasms Incorporating a Type III Internal Hemipelvectomy: a Novel Approach. World J Surg Oncol. Volume 10(222): 1-6. October 2012.
Wayne MG, Reddy SS, Pacholka J, Yuan S, Levi G. Inflammatory Pseudotumor of the Spleen: Case Report. Journal of Solid Tumors. Volume 2(2): 43-46. April 2012.
Chander RK, Iskander M, Reddy SS, Kigongo S, Ingram M, Madlinger RV. Laparoscopic Dissection of Para-Aortic Mass. Surgical Science. August 2011.
Martins PN, Reddy SS, Martins AB, Facciuto ME. Follicular Dendritic Cell Sarcoma of the Liver: An Unusual Presentation of a Rare Tumor and Literature Review. Journal of Hepatobiliary Pancreat Dis Int. Volume 10: 443-5. August 2011.
Clinical Locations
Primary Location
Fox Chase Cancer Center
333 Cottman Avenue
Philadelphia, PA 19111
Associate Professor, Department of Surgical Oncology
Attending Surgeon
Associate Program Director, Complex General Surgical Oncology Fellowship
Co-Director, Marvin & Concetta Greenberg Pancreatic Cancer Institute
Collaborating Member, Molecular Therapeutics
NCCN, Hepatobiliary Cancers Panel Member
Treatment Focus
Hyperthermic intraperitoneal chemotherapy (HIPEC), gastric cancer, hepatobiliary cancer, general and minimally invasive surgery
Research Program
Treatment Philosophy
I decided to join the Fox Chase Cancer Center team in conquering cancer because I saw first-hand the dramatic difference we can make here. I decided to continue my training in Philadelphia after completing my general surgery residency in New York City, under the tutelage of my father, also a surgeon who spent many years treating cancer. I completed a two-year fellowship in complex surgical oncology at Fox Chase, working closely with various multidisciplinary teams in caring for patients with colorectal, liver, pancreatic and stomach cancers, in addition to melanoma and sarcomas. Being trained by leaders in the field, I had the unique opportunity to hone my skills and expertise, and apply them to my own clinical practice.
I have extensive training in traditional open surgery, as well as laparoscopic and robotic techniques, allowing me to offer individualized care to patients. I have particular interests in the management of sarcomas and colorectal, melanoma and pancreatic cancers. The implementation of minimally-invasive surgical techniques to the management of colorectal cancer is routinely offered at Fox Chase, and similar techniques are used to address pancreatic diseases. I also have a keen interest in the use of hyperthermic intraperitoneal chemotherapy (HIPEC), following cytoreductive surgery for cancer of the peritoneum, including appendix cancer, peritoneal mesothelioma and pseudomyxoma peritonei. In addition to this, there is a necessity to understand the benefit of, and perform further research, incorporating HIPEC in patients with colorectal and gastric cancers, which our team will explore further.
The benefit of an NCI-designated cancer center is that we are able to offer many innovative strategies in treating all types of cancers. Whether through a national clinical trial or particular surgical technique, we optimize patient care to the individual. I believe the physician-patient relationship is one of the foundations to building a plan to treat cancer, and I offer guidance through each stage of treatment. Medicine has always been a family-oriented field for me; with my father being a surgeon, and mother an anesthesiologist, I take great pride in offering compassion and honesty in formulating individualized treatment plans for every patient and his or her family.
Follow on Twitter: @FCCCSurgOnc
Education
Educational Background
- Fellowship, Surgical Oncology Fellow, Fox Chase Cancer Center, Temple University Hospital, Philadelphia, PA
- Residency, General Surgery, Beth Israel Medical Center, New York, NY
Certifications
- Complex Surgical Oncology, 2014
- American Board of Surgery, 2012
- Board Certified in Complex Surgical Oncology
Memberships
- American College of Surgeons
- Clinical Robotics Surgical Association
- Association for Academic Surgery
- American Society of Clinical Oncology
- Society of Surgical Oncology
- Society for Surgery of the Alimentary Tract
- Pancreas Club
- American Cancer Society- Metropolitan Philadelphia Chapter
Honors & Awards
- Top Physicians Under 40 2020, Pennsylvania Medical Society
- The John (Drew) Ridge Fellowship Award in Surgical Oncology, 2014
- Resident Teaching Award, Beth Israel Medical Center, Albert Einstein College of Medicine,2011
- Resident Teaching Award, St. Vincent's Medical Center, New York Medical College, 2010
- Harriet Gold Foundation, Scholar in Humanism Award, New York Medical College, 2010
- Academic Achievement in Molecular Cell Biology, St. Vincent's Medical Center, New York, NY, 2009
- Pi Kappa Alpha, Honors Society, 2002-2003
- University of Connecticut Dean's List, 2002-2003
Research Profile
Research Interests
My research interest for colorectal malignancies focuses on the use of national cancer databases to assess the accuracy of clinical staging, to see if this has improved over time, and to observe reporting standards between academic institutions versus other centers. As treatment of colorectal cancers involve multimodality planning, accurate clinical staging proves to be the foundation on how best to deliver care.
I also have a strong research interest in the vascular resectability staging of pancreatic cancer. Currently under review is our preoperative venous and arterial staging for borderline resectable pancreatic cancers and whether we are able to predict from preoperative imaging the likelihood of clear margin achievement and prognosis. As treatment of borderline resectable pancreatic cancer continues to evolve, accurate preoperative vascular resectability staging is imperative to assess and guide multimodality therapy.
Publications
Selected Publications
Tharmalingam S, Reddy S, Sharda P, Koch CA. Severe Hypocalcemia and transient hypoparathyroidism after hyperthermic intraperitoneal chemotherapy. Thieme Connect 2020;Aug 7
Moten AS, Movva S, von Mehren M, Wu H, Esnaola NF, Reddy SS, Farma JM. Granular cell tumor experience at a comprehensive cancer center. J Surg Res, 226:1-7, 2018. PubMed
Barnica VH, Reddy SS, Wu H, Fang Z, Olszanski A, Farma JM. High Mitotic Rates in Patients with Cutaneous Melanoma. (Manuscript pending publication).
Reddy SS, Cooper HS, Ruth K, Chun YS, Watson JC, Hoffman JP. The Role of Adjuvant Chemoradiotherapy in Pancreatobiliary versus Intestinal Subtypes of Ampullary Cancers. Gastroenterology. Volume 144(5). 1107-1108. (Manuscript pending publication).
Reddy SS, Boukovalas S, Barnica V, Fang Z, Wu H, Farma JM. The Presence of Tumor Infiltrating Lymphocytes and their Role as a Prognostic Indicator for Melanoma. (Manuscript pending publication).
Reddy SS, Hoffman JP. Letter to the Editor Referencing, Kelly et al, Vein Involvement during Pancreaticoduodenectomy: is there a need for Redefinition of “Borderline Resectable Disease?” Journal of Gastrointestinal Surgery. February 2014.
Reddy SS, Leitman IM. Blood Transfusions in the Surgical Patient: A Gift of Life, but at What Cost? J Surg Res. Volume 181 (2): 216-218. May 2013.
Reddy SS, Leitman IM. Pharmacotherapy for Traumatic Spinal Cord Injury: The Science Behind the Promise. J Surg Res. Volume 181(2): 222-224. May 2013.
Reddy SS, Bloom ND. En Bloc Resection of Extra-Peritoneal Soft Tissue Neoplasms Incorporating a Type III Internal Hemipelvectomy: a Novel Approach. World J Surg Oncol. Volume 10(222): 1-6. October 2012.
Wayne MG, Reddy SS, Pacholka J, Yuan S, Levi G. Inflammatory Pseudotumor of the Spleen: Case Report. Journal of Solid Tumors. Volume 2(2): 43-46. April 2012.
Chander RK, Iskander M, Reddy SS, Kigongo S, Ingram M, Madlinger RV. Laparoscopic Dissection of Para-Aortic Mass. Surgical Science. August 2011.
Martins PN, Reddy SS, Martins AB, Facciuto ME. Follicular Dendritic Cell Sarcoma of the Liver: An Unusual Presentation of a Rare Tumor and Literature Review. Journal of Hepatobiliary Pancreat Dis Int. Volume 10: 443-5. August 2011.
Related Articles
30 PATIENT COMMENTS
-
5.0
March 21, 2022
Dr. Reddy & staff always courteous & professional he has a wonderful bed side manner.
-
5.0
March 21, 2022
I am familiar with the excellent care provided at Fox Chase Cancer Center. My husband was a pt. for about 20 yrs. I knew I needed to be treated here.
-
5.0
March 08, 2022
I think Dr. Reddy is an excellent doctor & an asset to Fox Chase.
-
5.0
February 23, 2022
Dr. Sanjay Reddy is very professional, competent, & caring. I know I'm in good hands with my upcoming surgery.
-
5.0
February 17, 2022
Dr Reddy and his team have exceeded my expectations with their compassion, communication skills, vast knowledge and empathy. I went to Fox Chase for a second opinion abd this was the best decision I ever made.
-
5.0
February 17, 2022
I am very pleased with Dr. Reddy and his staff.They show concern and understanding of my care.
-
5.0
January 31, 2022
Dr. Reddy explained everything to me in regular terms my son and I could understand and made me feel comfortable and well informed
-
5.0
January 24, 2022
I and my family are very pleased with Dr. Sanjay Reddy, MD.
-
No Star Ratings Available
January 04, 2022
Dr Reddy does an outstanding job I appreciate his professionalism expertise and personal approach with his patients
-
5.0
December 08, 2021
Dr. Reddy Is the best.
-
5.0
November 26, 2021
I was treated very well during the whole process.
-
5.0
November 24, 2021
Your staff are amazing. They work as a team and treat everyone like a friend. I was truely impressed with the medical care I received. Dr reddy and his team were amazing, the office staff were warm and welcoming.
-
5.0
November 15, 2021
Dr. Reddy and his team has provided excellent care. Dr. Reddy makes you feel as if you are his only patient and his caring attitude made me feel like all would be OK. Immediate trust and ease from day 1!!
-
5.0
November 13, 2021
My experience with [...] was better than I thought. Dr.Reddy was straight forward and that is want I wanted. I can for a second opinion but after I talked with him I definitely decided to stay with him.
-
5.0
October 09, 2021
Dr Reddy was fabulous and spoke with care and love
-
5.0
September 02, 2021
Accurate and honest assessment of condition in an easy to understand language
-
No Star Ratings Available
August 23, 2021
Dr. Reddy has gone beyond some of my expectations to honestly address my questions. He's kind, considerate, approachable and his manner instills confidence in his ability.
-
5.0
August 21, 2021
Good Experience. Thank You
-
5.0
August 16, 2021
Dr. Reddy always is an amazing doctor who did my net cancer surgery and has answered all my many questions. I have recommended Fox Chase to many people mostly because of Doctor Reddy and other staff care in this hospital!
-
5.0
July 28, 2021
Very Good experience!
LOAD MORE